The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
Primary Purpose
HIV Infections
Status
Completed
Phase
Locations
United States
Study Type
Observational
Intervention
Sponsored by
About this trial
This is an observational trial for HIV Infections focused on measuring HIV Positive
Eligibility Criteria
- Data analysis protocol
Sites / Locations
- National Institute on Drug Abuse, Biomedical Research Center (BRC)
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT01034800
First Posted
December 16, 2009
Last Updated
December 16, 2009
Sponsor
National Institute on Drug Abuse (NIDA)
1. Study Identification
Unique Protocol Identification Number
NCT01034800
Brief Title
The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
Official Title
The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
Study Type
Observational
2. Study Status
Record Verification Date
January 2009
Overall Recruitment Status
Completed
Study Start Date
September 2006 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
National Institute on Drug Abuse (NIDA)
4. Oversight
5. Study Description
Brief Summary
The lack of success in treating substance abuse may be contributed to by a limited understanding of the clinical neurobiology of drug abuse. A better understanding of such deficits might aid in the development of more relevant pharmacological and psychosocial treatment approaches. Thus, the purpose of this study is to test the hypothesis that repetitive illicit drug use may be associated with cortical and subcortical structural abnormalities, vascular abnormalities, as well as neuropsychological decrements. Additionally, a battery of psychological tests are administered to provide information about demographics, drug use, neurocognitive measures, and personality structures....
Detailed Description
The lack of success in treating substance abuse may be contributed to by a limited understanding of the clinical neurobiology of drug abuse. A better understanding of such deficits might aid in the development of more relevant pharmacological and psychosocial treatment approaches. Thus, the purpose of this study is to test the hypothesis that repetitive illicit drug use may be associated with cortical and subcortical structural abnormalities, vascular abnormalities, as well as neuropsychological decrements. Additionally, a battery of psychological tests are administered to provide information about demographics, drug use, neurocognitive measures, and personality structures.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV Infections
Keywords
HIV Positive
7. Study Design
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Data analysis protocol
Facility Information:
Facility Name
National Institute on Drug Abuse, Biomedical Research Center (BRC)
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21224
Country
United States
12. IPD Sharing Statement
Learn more about this trial
The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
We'll reach out to this number within 24 hrs